BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31140112)

  • 1. Preoperative visual evoked potential in the prediction of visual outcome after pituitary macroadenomas surgery.
    Taghvaei M; Sadrehosseini SM; Ostadrahimi N; Sarraf P; Zeinalizadeh M
    Pituitary; 2019 Aug; 22(4):397-404. PubMed ID: 31140112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurophysiologic follow-up in patients with hypophyseal adenoma operations].
    Heinemann B; Weik R; Steudel WI; Ruprecht KW
    Ophthalmologe; 1998 Jan; 95(1):28-32. PubMed ID: 9531798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of intraoperative monitoring of visual evoked potentials in transsphenoidal surgery.
    Kamio Y; Sakai N; Sameshima T; Takahashi G; Koizumi S; Sugiyama K; Namba H
    Neurol Med Chir (Tokyo); 2014; 54(8):606-11. PubMed ID: 25070017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of visual evoked potential monitoring during trans-sphenoidal pituitary surgery.
    Chacko AG; Babu KS; Chandy MJ
    Br J Neurosurg; 1996 Jun; 10(3):275-8. PubMed ID: 8799538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of optic nerve functions in subacute combined degeneration using visual evoked potential and diffusion tensor imaging-a pilot study.
    Kalita J; Soni N; Dubey D; Kumar S; Misra UK
    Br J Radiol; 2018 Nov; 91(1091):20180086. PubMed ID: 29987983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Influencing Visual Field Recovery after Transsphenoidal Resection of a Pituitary Adenoma.
    Lee DK; Sung MS; Park SW
    Korean J Ophthalmol; 2018 Dec; 32(6):488-496. PubMed ID: 30549473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of Nd:YAG laser in pituitary surgery and evaluation of visual function by visual evoked potential (VEP).
    Gökalp HZ; Egemen N; Culcuoglu A; Naderi S; Zorlutuna A
    Neurosurg Rev; 1992; 15(3):193-7. PubMed ID: 1407607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decision Making for Patients With Concomitant Pituitary Macroadenoma and Ophthalmologic Comorbidity: A Clinical Controversy.
    Hajiabadi M; Alimohamadi M; Fahlbusch R
    World Neurosurg; 2015 Jul; 84(1):147-53. PubMed ID: 25769486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discrepancy between structural and functional visual recovery in patients after trans-sphenoidal pituitary adenoma resection.
    Qiao N; Ye Z; Shou X; Wang Y; Li S; Wang M; Zhao Y
    Clin Neurol Neurosurg; 2016 Dec; 151():9-17. PubMed ID: 27728836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual outcome of surgically managed pituitary adenomas followed-up at the Yaoundé Central Hospital.
    Njami VA; Epee E; Nguifo Fongang EJ; Bello F; Ekoumelon R; Bukam ED; Sobngwi E; Djientcheu VP
    Br J Neurosurg; 2018 Oct; 32(5):521-527. PubMed ID: 30073855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Visual system function in patients after surgery for intracranial tumors].
    Pojda-Wilczek D; Pojda SM; Hendryk S; Herba E; Zatorska B; Jochan K
    Neurol Neurochir Pol; 2000; 34(6):1173-86. PubMed ID: 11317494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical value of the multi-channel PVEP and PERG in the diagnosis and management of the patient with pituitary adenoma: a case report.
    Lachowicz E; Lubiński W
    Doc Ophthalmol; 2018 Aug; 137(1):37-45. PubMed ID: 29968203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of multifocal visual evoked potential, static automated perimetry, and optical coherence tomography findings for assessing visual pathways in patients with pituitary adenomas.
    Qiao N; Zhang Y; Ye Z; Shen M; Shou X; Wang Y; Li S; Wang M; Zhao Y
    Pituitary; 2015 Oct; 18(5):598-603. PubMed ID: 25349031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive improvement of impaired visual acuity during the first year after transsphenoidal surgery for non-functioning pituitary macroadenoma.
    Dekkers OM; de Keizer RJ; Roelfsema F; Vd Klaauw AA; Honkoop PJ; van Dulken H; Smit JW; Romijn JA; Pereira AM
    Pituitary; 2007; 10(1):61-5. PubMed ID: 17318437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors for the development of visual loss in patients with pituitary macroadenomas and for visual recovery after optic pathway decompression.
    Monteiro ML; Zambon BK; Cunha LP
    Can J Ophthalmol; 2010 Aug; 45(4):404-8. PubMed ID: 20648089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Predictive Role of Intraoperative Visual Evoked Potentials in Visual Improvement After Endoscopic Pituitary Tumor Resection in Large and Complex Tumors: Description and Validation of a Method.
    Feng R; Schwartz J; Loewenstern J; Kohli K; Lenina S; Ultakan S; Iloreta AM; Govindaraj S; Bederson J; Banik R; Shrivastava R
    World Neurosurg; 2019 Jun; 126():e136-e143. PubMed ID: 30794978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual parameters in patients with pituitary adenoma before and after transsphenoidal surgery.
    Marcus M; Vitale S; Calvert PC; Miller NR
    Aust N Z J Ophthalmol; 1991 May; 19(2):111-8. PubMed ID: 1930993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifocal visual evoked potential recordings in compressive optic neuropathy secondary to pituitary adenoma.
    Jayaraman M; Ambika S; Gandhi RA; Bassi SR; Ravi P; Sen P
    Doc Ophthalmol; 2010 Dec; 121(3):197-204. PubMed ID: 20821036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Evaluation of Visual Function in Patients With Orbital Fracture by Visual Electrophysiology and Visual Field Examination.
    Liu SR; Li M; He FL; Li ZK; Fan XQ
    J Craniofac Surg; 2018 Jan; 29(1):188-192. PubMed ID: 29286999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Visual field defects in 169 cases of pituitary adenomas].
    Shen MQ; Ye W; Zhang YY; Chen J
    Zhonghua Yan Ke Za Zhi; 2009 Dec; 45(12):1074-9. PubMed ID: 20193428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.